Anti-tumor necrosis factor therapy in Bulgarian pediatric patients with inflammatory bowel disease - an 8-year experience of a referral center.
Rayna R Shentova-EnevaDenitza R KofinovaMila Zh BaychevaPetyo G HadzhiyskiHristo B NaydenovPenka G YanevaElena A LazarovaPublished in: Folia medica (2023)
Anti-tumor necrosis factor (anti-TNF) therapy has become a mainstay in the treatment of patients with inflammatory bowel disease over the past few decades.